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Summary 
Introduction: In the last three decades, prenatal Down’s syndrome screening, 
which provides women with information about their individual risk of having an affected 
pregnancy, has become one of the most rapidly evolving fields of medicine. The 
development has resulted in the introduction of formal screening programmes in several 
countries and has promoted the spread of ad hoc screening in some others.  
Objectives: Studying the ethical impacts of prenatal Down’s syndrome screening is 
deemed essential, as while screening creates new perspectives for the parents to tackle the 
problems of Down’s syndrome, it also induces new complex problems. The objectives of 
the PhD thesis are to answer the question whether the implementation of prenatal Down’s 
syndrome screening is ethically justifiable at all, and, if the answer is positive, to explore 
the moral issues that should be taken into account through its application.  
Methods: In those territories where the Thesis has added new information to the 
previously existing knowledge, the biomedical ethics approach, the interpretive ethics 
approach, and the sociological method of a questionnaire study were applied. Where data 
were collected on already existing knowledge, literature review was performed. 
Results: By analysing the competing goals of prenatal screening (prevention and 
enhancing autonomy), the PhD thesis has contended that the implementation of prenatal 
Down’s syndrome screening is ethically acceptable, provided that its goal is defined as 
enhancing the parents’ reproductive autonomy, and that the voluntary participation of 
women is ensured. The Thesis has revealed that the goal of enhancing reproductive 
autonomy has an effect on the overall process of screening. Of these implications, first, the 
reasons of uncertainty concerning the use of appropriate screening methods were studied, 
then the professionals’ and the pregnant women’s attitudes to screening were interpreted 
and a guideline was constructed to help professionals give verbal and written pre-test 
information. Later on, the views of genetic counsellors on the goal of genetic counselling 
and the genetic counselling expectations of pregnant women were explored. Based on 
these data, the abandonment of non-directive consultation style and the application of 
interpretive genetic counselling have been suggested. The new, interpretive method was 
elaborated in detail by the Thesis. By acknowledging the social impacts of prenatal 
screening, the Thesis has supported the development of those forums where the prenatal 
and postnatal issues of Down’s syndrome are discussed jointly. 
Conclusion: The PhD thesis can serve as an example for presenting how medical 
ethics theories and experiences deriving from everyday medical practice can be combined. 
Thus, its results can be utilised in the fields of prenatal screening, genetic counselling and 
academic education of medical ethics. 
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1. Introduction 
Down’s syndrome or trisomy 21, as it is frequently called because of its 
chromosomal origin identified by J. Lejeune in 1959, is the most common genetic cause of 
mental disability and occurs in approximately one in seven hundred births [1,2]. Besides 
learning disabilities, which varies from mild (IQ 50-70) to severe (IQ 35-50), individuals 
with Down’s syndrome can have other serious disorders, e.g. heart defects, gastrointestinal 
problems, hearing loss, ophthalmic disorders, susceptibility to infections, early Alzheimer 
disease [3]. With the development of medicine, most of these diseases have become 
treatable and owing to early intervention programmes beginning in infancy, the physical 
and cognitive ability of the affected children may be improved. So, they can develop the 
skills of walking, talking, dressing, etc. although, with a delay compared to other children, 
and resulting from special education acquired in separated or inclusive classes, many 
affected children learn to read and write. In a supportive environment, several adults with 
Down’s syndrome can hold regular job and can lead an assisted independent life [4,5]. 
The relatively high incidence of Down’s syndrome and the severity of diseases 
associated with it have generated an increased interest of medicine towards this genetic 
condition, and in the last three decades, prenatal Down’s syndrome screening has become 
one of the most rapidly evolving fields of biomedicine. Nowadays, by the use of screening 
and diagnostic technologies, prenatal medicine can offer women information about their 
individual risk of having a pregnancy with Down’s syndrome, which risk may significantly 
differ from their age-related risk, and for women with an increased chance of having an 
affected foetus, the possibility of accurate diagnosis. These achievements have resulted in 
the introduction of nationally organised, universally provided prenatal Down‘s syndrome 
screening in a growing number of countries [6-9]. In some other states, like in Hungary, 
which lack a formal screening programme, the professional considerations and the parental 
choices have contributed to the spread of ad hoc screening that works outside central 
coordination [10-12].  
1.1. Research objectives 
In ethical terms, prenatal genetic screening for Down’s syndrome constitutes a 
special territory of the application of modern medical technology, and these specialities 
derive from the characteristics that it is an antenatally performed screening procedure and 
it screens for a disability condition which is not life threatening but causes severe 
handicap. Since prenatal Down’s syndrome screening touches the sensitive fields of 
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reproductive decisions and social attitudes towards people with disability, its history has 
been accompanied by constant debates. The proponents, the majority of pregnant women 
and obstetricians, have welcomed the new opportunities provided by prenatal screening 
[13], and this enthusiasm has made Down’s syndrome screening to be the standard 
component of antenatal care and has launched the proliferation of screening methods. The 
opponents, feminist activists and disability rights advocates, have criticised the negative 
effects and have questioned the necessity of screening on the grounds that it forces women 
to make unwanted decisions, it has a “search and destroy” mission concerning the affected 
foetuses, and it includes discriminative and eugenic hints against disabled people [14-18]. 
The inherent dichotomy hidden in prenatal Down’s syndrome screening, meaning that 
while it creates new perspectives for the parents to tackle the problems of Down’s 
syndrome, it also induces new complex medical and social problems, renders the study of 
the ethical implications of this medical procedure essential. The ethical analysis has the 
tasks to answer the question whether the implementation of prenatal Down’s syndrome 
screening is ethically justifiable at all, and if the answer is positive, to explore the moral 
issues that should be taken into consideration through the application of prenatal Down’s 
syndrome screening. In Hungary, these topics have not yet been studied, although, some of 
them have been thoroughly discussed in the international literature. Thus, in the 
dissertation, I intend to present the results of my theoretical and empirical researches that 
have added new elements to the knowledge on the ethical issues of prenatal Down’s 
syndrome screening. Further aims of the doctoral paper are to give practitioners an ethical 
guideline on prenatal Down’s syndrome screening and to outline a methodological 
framework of reproductive genetic counselling, which follows prenatal screening in 
several cases. A fulfilment of these tasks necessitates studying the following topics: 
1) Ethical acceptability of prenatal Down’s syndrome screening: What are the aims of 
the application of prenatal Down’s syndrome screening? Are these aims similar to the 
aims of other kinds of population screening programmes, or are they different? Are 
these aims ethically acceptable? 
2) Implications of an ethically justifiable aim on medical practice: What practice 
should be offered to meet the ethically justifiable aim of screening? Which screening 
methods should be used? How much and what kind of information should be disclosed 
to women and couples about prenatal screening? What kind of doctor-patient interaction 
should be formed through genetic counselling concerning Down’s syndrome? What are 
the counsellees’ expectations on genetic counselling? Can these expectations be 
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satisfied by applying non-directive genetic counselling, or the use of a newer method is 
necessary? What are the characteristics of this new method of genetic counselling? 
3) Wider social impacts of the application of prenatal Down’s syndrome screening: 
What are the wider social impacts of screening? By what means can socially, culturally 
and morally important values be preserved through the implementation of prenatal 
Down’s syndrome screening? What changes are required in order to adjust the 
Hungarian prenatal screening practice to widely agreed ethical principles? 
The need to answer these questions has been strengthened by the current public interest 
emerging towards the introduction of universal prenatal screening in Hungary [19,20], and 
by the circumstance, that the importance of first trimester nuchal translucency screening, 
which is considered as an indispensable part of the most effective screening methods, has 
been discovered by physicians working at the Medical Faculty of University of Szeged, 
Hungary [21]. This discovery has inspired the co-operation of physicians and medical 
ethicists in Szeged, which is regarded unique in the Hungarian health care context, and the 
results of this common work are presented in the doctoral paper.  
1.2. Research methods 
To acquire data about what is already known on the topic of the dissertation, a 
literature review was performed, being the basic method of every scientific research, which 
has covered papers dealing with theoretical medical ethics, the special ethical problems of 
prenatal screening and diagnosis, and the medical technology of prenatal Down’s 
syndrome screening. In those territories where the doctoral paper has added new 
information to the previously existing knowledge, three types of methods were applied: the 
biomedical ethics approach, the interpretive ethics approach, and the empirical sociological 
method of a questionnaire study. 
1.2.1. Biomedical ethics approach 
Since biomedical ethics, or briefly bioethics, the prevailing view of recent medical 
ethics thinking, has been developed by the purpose of addressing and solving the ethical 
problems posed by technological medicine, adopting this system to the issues of prenatal 
Down’s syndrome screening seems obvious [22-26]. A justification given by the 
biomedical ethics approach can ensure widespread acceptance of the use of a medical 
procedure, as in making moral judgements about what is right and what is wrong, bioethics 
combines the traditional ideas of medicine, such as beneficence and non-maleficence and 
the values of democratic societies, such as respect for autonomy and justice. These four 
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principles are also deemed as a consensus between the two main philosophical ethical 
theories, deontology and utilitarianism. Therefore, the moral commitments determined by 
the four principles can fulfil both the criteria of deontology, that a morally right action 
should follow the moral duties, and of utilitarianism, that a morally right action should 
maximise the overall welfare. A firmly justified medical decision is expected to take into 
consideration more than one ethical principle [27], since in biomedical ethics moral duties 
are perceived as prima facie duties that can be overridden if good reasons are found, 
however, their infringements leave moral traces. By relying on the ethical reasoning 
method provided by the four principles, in the dissertation, the traditional goal of prenatal 
screening (goal of prevention) has been challenged and another, ethically consistent goal 
(enhancing parents’ autonomy) has been proposed. The bioethics approach has also been 
fruitfully used when studying the social impacts of prenatal screening and the issues of 
respect for autonomy, which principle has taken precedence over the other ones in the 
medical practice of Western-type societies. 
1.2.2. Interpretive ethics approach 
While, in the international literature, interpretive ethics is regarded as an alternative 
or a complementary approach relating to the dominant bioethics view [28-32], in Hungary, 
this approach has been hardly known yet, so, the application of interpretive ethics to 
prenatal Down’s syndrome screening should be considered as a novelty of the dissertation. 
The interpretive approach emphasises that through the medical interaction, 
interpretive processes take place where the physician interprets the patient’s symptoms in 
order to set up a diagnosis and tries to explore what meaning is attributed to the disease by 
the patient in order to provide proper help, which is not merely medical but also 
psychological and emotional. By recognising the connection between medical practice and 
the process of interpretation, the most important doctrines of philosophical hermeneutics 
elaborated by Hans-Georg Gadamer [33] may be incorporated in the methods of medical 
science. The ideas that human understanding is always influenced by the context in which 
it occurs, and that in the process of understanding both the phenomenon being interpreted 
and the interpreter interact with each other have strongly affected medical ethics. Thus, the 
interpretive ethics approach contends that the moral deliberations of patients are 
significantly determined by their cultural and social traditions and not only by the 
rationally acknowledged personal values, as bioethics has previously presumed [34]. The 
interpretive approach places the doctor-patient relationship into a new perspective as well; 
it rejects the view of traditional medical ethics that considers patients as only the passive 
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subjects of medical interventions, and it also denies the concept of bioethics that regards 
physicians as merely technicians whose expertise is restricted only to technical knowledge 
and skills [35]. In interpretive ethics, the doctor-patient interaction is viewed as a 
dialogical relationship in which both parties play active roles; the physician and the patient 
mutually share their knowledge (professional and lay) and experience (scientific and 
personal) that can result in a common interpretation of the situation caused by the disease, 
that differs from the presumptions of both participants. When, in collaboration with 
colleagues, I have applied this new approach to the ethical questions of genetic 
counselling, a deeper insight into the dynamics of the doctor-patient relationship has been 
gained [36]. The novelty of this work were appreciated by a prestigious, peer-reviewed 
international journal that, besides the publication of the results of this research, initiated a 
debate on the problems of genetic counselling based on the issues addressed by our paper 
[37]. An elaboration of the method of interpretive genetic counselling has also been owed 
to the application of this new method, and our paper written on this issue has been found 
worthy for publication by an international journal with an impact factor [38]. 
1.2.3.  Empirical sociological approach: a questionnaire study 
In the dissertation, the biomedical and interpretive ethics approaches were applied 
to perform normative ethical analysis, e.g. to make considerations about what ought to be 
done, however, when descriptive ethical questions were studied, e.g. different moral 
attitudes on a given issue were explored, a sociological research method was used. Owing 
to a co-operation with the Department of Medical Genetics, University of Szeged, I had the 
opportunity to conduct descriptive ethical research on the expectations of pregnant women 
on genetic counselling concerning Down’s syndrome. Previously, no data on this issue 
have been available in Hungary. Consequently, the normative moral recommendations of 
the dissertation are based not only on theory but also on facts coming from day-to day 
medical practice. 
The empirical research included a quantitative questionnaire study, which was 
conducted among pregnant women visiting the genetic counselling clinic of the 
Department of Medical Genetics, University of Szeged. The questionnaire was based on 
the related international and Hungarian literature, was self-administered by the 
respondents, and was approved by the institutional ethics committee. The analysis of the 
empirical data required the use of a statistical programme provided by the Statistical 
Package for Social Sciences, version 15.0 (SPSS, Chicago, IL, USA). 
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2. Goals of prenatal Down’s syndrome screening – competing 
principles of beneficence and respect for autonomy 
A study of the ethical issues of prenatal Down’s syndrome screening should begin 
with answering the crucial question whether the application of this medical procedure is 
ethically acceptable at all. Since a response to this question is strongly affected by the 
goals of prenatal Down’s syndrome screening, in the following, I critically examine the 
two competing concepts given on this topic in the international and the Hungarian medical 
literature. As the positions relating to the ethical acceptability of prenatal screening and to 
the goal of it can influence both public policy and doctor-patient relationship, examining 
these questions with scrutiny has of vital importance. When criticising the intuitively given 
aim of prenatal screening and endorsing a more sophisticated goal, I intend to help 
professionals to choose an ethically consistent goal for their practice.  
2.1. Goal of disease prevention: a critique 
The first approach, motivated mainly by public health considerations, claims that the 
goal of prenatal screening is disease prevention; prenatal screening tests can be viewed as a 
form of secondary prevention, which completed with selective abortion, can reduce the 
number of newborn babies having Down’s syndrome [39-44]. This position is influenced 
by the view that population screening programmes, such as mammography, colorectal or 
prostate cancer screening, are thought to belong to the realm of preventive medicine, 
which, by identifying those at increased risk, can facilitate early diagnosis and successful 
treatment. Furthermore, the general tendency that almost 80-90% of the parents decide 
against the continuation of a pregnancy affected by Down’s syndrome might suggest that 
prenatal Down’s syndrome screening serves preventive purposes [45,46]. Nonetheless, I 
challenge the goal of prevention by stating that this aim is intuitively given, and the lack of 
systematic ethical analysis reflected in the definition hinders the proponents of this view in 
taking into account the differences of prenatal genetic screening compared to other 
population screening programmes, and in recognising the wider social impacts of the goal.  
2.1.1. Problems with the ethical justification of the goal of prevention 
To illuminate the differences of prenatal screening and other types of population 
screening, I perform an ethical justification by using the reasoning method of biomedical 
ethics. When the implementation of population screening programmes is justified, 
generally, the principle of beneficence is applied as a moral argument. Benefiting the 
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patient, contributing to the health-related welfare of others has been constituted a 
fundamental professional duty of physicians since the time of Hippocrates, and in 
nowadays biomedical ethics the duty of beneficence requires preventing harm 
(vaccination, etc.), removing harm (administering medication, surgical operations, etc.), 
and promoting good (biomedical researches, etc.) [23,47]. Naturally, screening 
programmes that are followed by early diagnosis and effective treatment can benefit the 
patient having the disease by preventing harm, so their implementation can be approved on 
the grounds of beneficence. However, in the case of Down’s syndrome, no curing 
procedure exists and only the termination of affected pregnancies can be offered to the 
parents, thus, by screening, not the disease but the birth of a baby with the condition may 
be “prevented”. Consequently, the foetus having the disease is not benefited as its abortion 
is expected in the sense of prevention. Moreover, it is theoretically dubious whether the 
foetus can be benefited or harmed at all, since, in biomedical ethics, only those can be 
benefited or harmed who have special moral status and until now, no consensus has been 
developed on the moral status of foetuses. Therefore, a decision whether or not a foetus is 
deemed as a moral person that can be benefited or harmed depends on the discretion of the 
parents, albeit among the conditions provided by the law.  
As the application of the principle of beneficence has proved inadequate in the case 
of foetuses, now, this principle is applied to pregnant women participating in prenatal 
screening. The examination reveals that through Down’s syndrome screening, not the 
health of pregnant women is promoted at the first place, but an opportunity is provided 
them to make a decision about the future of an affected pregnancy, and the territory of 
making choices belongs to the principle of autonomy and not to the principle of 
beneficence. The idea that, through antenatal Down’s syndrome screening, the key issue is 
the parents’ decision-making is well demonstrated by the resolutions of those parents - 
even though their numbers are only few - who participate in prenatal screening but refuse 
the abortion of an affected foetus, for which action the goal of prevention cannot give any 
explanation.  
2.1.2. Negative social implications of the goal of prevention 
While it is recognisable, that the ethical justification of the goal of prevention is 
problematic, since the moral rightness of this aim cannot be proved by the principle of 
beneficence, the goal of prevention raises further ethical problems by its possible negative 
implications on widely supported social values. For example, the goal of prevention fails to 
recognise that deciding about the future of a Down’s syndrome pregnancy represents a 
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genuine reproductive decision and not a medical decision, where the decision-makers 
should be the parents and not the medical professionals. Because of the underlying 
presumption of the goal of prevention that the affected pregnancies will be terminated, 
parents may think that their reproductive liberty has suffered interference by third parties 
e.g. by providers of screening tests or health care decision-makers, who expect or suggest a 
decision which belongs exclusively to the parents’ authority. It is just the notion of respect 
for reproductive autonomy that differentiates the expression of “preventing the birth of a 
baby with Down’s syndrome” from “avoiding the birth of a baby with Down’s syndrome” 
in ethical terms [48]. As, while the first expression may imply administrative, regulative or 
even coercive measures that constrain reproductive liberty, the last refers to allowing 
parents to make decisions on procreation that respects reproductive freedom.  
Considering prevention as the goal of prenatal screening may violate the sensitivity 
and interest of families bringing up children with Down’s syndrome as well [49], since it is 
frequently associated with the argument that the care of people with Down’s syndrome 
imposes severe burden not only on families but also on society. The parents generally 
interpret this argument as discriminative and contradictory to the principle of justice, as 
based on social justice, people in disadvantageous situation rightly expect the support of 
the community in order to improve their chance for a better life.  
The aim of prevention encourages the rise of eugenic thoughts too, as by 
emphasising the community’s interests in reducing the number of newborn babies with 
Down’s syndrome, the idea seems to be suggested that the community supports the 
selection of foetuses based on their genetic make-up. However, in 20th century history, 
eugenic thoughts served corrupt political aims and led to tragic consequences, so, 
refraining from eugenics constitutes an ethical imperative for recent medical genetics 
[50,51].  
In summary, the ethical analysis has pointed out that, by contrast to other population 
screening programmes, the goal of prevention cannot be considered as an ethically 
acceptable aim of prenatal Down’s syndrome screening as it cannot be justified by the 
principle of beneficence. Furthermore, the goal of prevention may compromise the doctor-
patient relationship by giving a tacit approval to the physicians’ influences on the parents’ 
reproductive decisions and may convey negative messages on the social value of people 
with disability. Because of these reasons, I suggest omitting prevention out of the goals of 
prenatal Down’s syndrome screening. 
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2.2. Goal of enhancing parents’ reproductive autonomy: an approval 
The other concept defines the goal of prenatal Down’s syndrome screening as 
enhancing parents’ reproductive autonomy by disclosing information about the genetic risk 
of the foetus on that basis parents can make informed decision about the future of the 
pregnancy and about their family planning [39,43,52,53]. The ethical justification of this 
aim can be performed by alluding to the principle of respect for autonomy, which is a 
prima facie moral duty in biomedical ethics and requires the recognition of the right of 
persons to self-governance insofar as their actions do not violate the same rights of others 
[23]. Noteworthy, that while a rational person’s right to self-governance is widely 
supported, a future child’s rights to autonomy is ethically debated and is associated with 
the issue of the moral status of foetuses. Thus, promoting the reproductive preferences of 
parents and supporting them to control the most intimate sphere of their life exemplify 
respect for autonomy, and many actions belonging to this field can be morally justified.  
2.2.1. Scope of reproductive autonomy 
In the developed countries, reproductive autonomy includes the rights to not 
procreate by using contraceptive methods and abortion; to procreate by using fertility 
treatments and assisted reproductive technologies; to decide the timing and number of 
children; to choose the mood of labour; and also to promote the health of a future child by 
using prenatal screening and diagnostic services [54-56]. Nonetheless, the scope of 
reproductive liberty is not without limits and the parents’ reproductive preferences are not 
accepted without exceptions. For example, using selective abortion for sex selection based 
on social and not medical reasons is prohibited in the majority of countries, since this 
selection generally happens to the disadvantage of female foetuses and Western-type 
societies are not willing to support a policy which may strengthen discriminative 
tendencies [42,57]. However, contrary to the fact that prenatal screening services are also 
accused by perpetuating discrimination against people with disability, selective abortion of 
a disabled foetus has remained an important part of the parents’ reproductive autonomy. In 
this social practice, according to my view, a widely shared belief about the differences of 
disability and discrimination is reflected. As, while gender-based discrimination is caused 
by social arrangements and can be solved by social measures, the learning disabilities of 
people with Down’s syndrome are caused by objective, physiological factors and cannot be 
totally eliminated by anti-discriminatory social policy. (Nonetheless, its negative impacts 
can be exaggerated by discriminative social attitudes.) Despite feminist views asserting 
that a woman should have the right to terminate an unwanted pregnancy, however, if she 
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decides to have a child, she has to accept any kind of child [58], I contend that because of 
the special tasks and responsibilities families bringing up children with disability have to 
face, leaving decisions about the future of an affected pregnancy on the parents is morally 
justified.  
For the reason that prenatal Down’s syndrome screening aims to enhance the free 
reproductive choices of women, special attention should be paid to their voluntary 
participation as, sometimes, social or familial expectations make difficult to reject to 
participate in screening, or to continue with an affected pregnancy. Providers of prenatal 
screening should also be aware that while this procedure enhances parents’ reproductive 
choices, its spread may involve the danger that the birth of a disabled child would be 
considered as a result of the deliberate choices of the parents, which may reduce social 
sympathy and support given to these families [59]. 
2.2.2. Moral status of foetuses with disability 
When including the selective abortion of disabled foetuses in the reproductive rights, 
it is presumed that foetuses with disability possess lower moral status than persons or non-
disabled foetuses [60]. The ethical literature offers moral arguments underlying this 
presumption; for example, the argument from “potential” represents a conservative idea, 
which is accepted even by some protestant churches in the case of disabled foetuses [61]. 
According to this view, embryos and foetuses are not human persons, however, they have 
the potential to develop into it. Our moral obligations towards them, meaning whether or 
not they can be destroyed, depend on the extent they include the potential to develop into a 
full human person. Since foetuses with disability posses a smaller degree of this potential 
than non-disabled foetuses, their termination can be ethically justified [62].  
The argument of “replaceable foetuses” demonstrates a utilitarian idea, which 
demands that in decisions about the future of a disabled foetus, the utilitarian principle of 
maximising the overall welfare of all affected parties should be considered [63]. The 
utilitarian calculus on the amount of happiness and misery presumably produced by the 
continuation or the termination of an affected pregnancy is performed by comparing the 
quality of life of a future disabled child with that of a future non-disabled child. As the life 
of a future disabled child shows a lower quality than that of a future non-disabled child, 
according to the utilitarian principle, the parents have to choose the termination of an 
affected pregnancy, provided, they can conceive a non-disabled child in the future [64].  
The lack of consensus on the moral status of foetuses has an influence on the issue of 
the moral status of disabled foetuses as well. Thus, the above-mentioned arguments are 
acceptable for those parents who are considering the termination of an affected pregnancy 
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but are unacceptable for those who, in accordance with the Catholic Church, attribute full 
moral status to the foetus. In the European countries, the laws on the abortion of Down’s 
syndrome foetuses are varying greatly. Generally, although under strict control, it is 
allowed before 24 weeks of gestation, when the parents have received the results of mid-
trimester amniocentesis, but the foetus has not yet reached the threshold of viability [6,65]. 
2.2.3. Social implications of the goal of enhancing reproductive autonomy 
Sometimes, the goal of enhancing the parents’ reproductive autonomy is criticised on 
the grounds that professionals of prenatal medicine have shifted the responsibility away 
from themselves, since by this goal, the discriminative and eugenic features of prenatal 
screening can be interpreted as being the unintended consequences of the parents’ 
individual choices [18,42]. While this objection points to the undesirable consequences of 
discussing the issues of prenatal Down’s syndrome screening only from the perspectives of 
the screening participants, the aim of enhancing reproductive choices should be regarded 
as a thoughtfully given definition that considers both the interests of the parents and the 
wider social impacts of screening. This aim takes seriously the parents’ reproductive 
autonomy, as it does not include any expectation about the content of parental decisions 
about the future of an affected pregnancy; respects the sensitivity of families having 
children with disability, as it does not convey discriminatory meaning against disabled 
people; and refrains from eugenics, as it does not involve concerns about the condition of 
the human gene pool. 
At the end of the ethical analysis of the goal of prenatal Down’s syndrome screening, 
the initial question should be answered whether the implementation of this medical 
procedure is ethically acceptable. In answer to this question, I assert that if prenatal 
Down’s syndrome screening aims to enhance the parents’ reproductive autonomy, and if 
women’s voluntary participation is ensured, its implementation is ethically acceptable. As 
the goal of enhancing parents’ reproductive autonomy can be ethically approved by the 
principle of respect for autonomy, and as this goal takes also into account the moral 
requirements of the principle of justice by rejecting eugenic and discriminatory tendencies, 
I contend that only this goal can give an ethically consistent justification to prenatal 
screening. Obviously, a definition of the goal of prenatal screening can give only a frame 
to practice good medical care, but its realisation depends on the quality of the doctor-
patient relationship and on the supportive social and health care contexts, which are 
indispensable in order to guarantee the really free choices of women through the whole 
process of prenatal Down’s syndrome screening.  
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3. Confusion on the issue of what screening technology should 
be applied 
On the account that prenatal Down’s syndrome screening promises to enhance the 
parents’ reproductive autonomy by giving reliable information on the genetic risk of the 
foetus, choosing the screening technology fulfilling best this task is regarded essential. The 
ethical problems derive from the feature of screening that it can identify women with an 
increased chance of having an affected pregnancy by using biochemical and ultrasound 
markers (Table 1), however, it can never reach the accuracy of invasive diagnosis. False 
positive and false negative results are inseparable parts of screening that may induce 
negative psychological consequences in women, and in cases of screen positive results, 
diagnostic procedures (amniocentesis, chorion villus sampling) may result in about 1% 
foetal loss. Therefore, screening technologies should meet the ethical requirement of “do 
no harm” concerning the health of mothers and foetuses, so they should perform low false 
positive rate. Furthermore, in the sense of utility, they should maximise the advantages for 
all who are affected, so they should present high detection rate and cost-effectiveness.  
Table 1: Currently applied ultrasound and biochemical screening markers for Down’s syndrome [66-68] 
 
First trimester Second trimester 
Increased nuchal translucency (NT) 
Absent nasal bone  
Tricuspid regurgitation  
Increased impedance in ductus venosus 
 
 
Ultrasound 
markers (based 
on foetal 
anatomy) 
 
Increased nuchal fold (NF); Absent nasal bone; 
Congenital heart defects; Intrauterine growth 
restriction; Mild cerebral ventriculomegaly; 
Choroid plexus cysts; Cystic hygromas; 
Echogenic intracardiac foci; Increased intestinal 
echogenicity; Duodenal atresia ("double-bubble 
sign"); Renal pelvis dilation; Shortened humerus 
and femur; Increased iliac wing angle; 
Clinodactyly and hypoplasia of the fifth finger; 
Increased space between first and second toes; 
Two-vessel umbilical cord 
Biochemical 
markers (based 
on maternal 
blood serum 
components) 
Pregnancy associated plasma protein A (PAPP-A) 
Free β human chorionic gonadotrophin (free β-
hCG)  
Alfa foetoprotein (AFP) 
Total or free β-hCG 
Unconjugated oestriol (uE3) 
Inhibin A  
3.1. Debated questions of screening technology  
When reviewing the relevant literature, confusion and uncertainty have been 
revealed on the questions of the most effective and safest screening methodology. 
Although, the literature has generally mentioned the great number of methods as the source 
of uncertainty [69], the ethical consequences of this uncertainty have not been 
systematically studied. Therefore, I think necessary to give an overview about the manifold 
reasons of the confusion emerging on the use of the appropriate screening method and to 
summarise the ethical requirements that screening strategies have to fulfil in order to 
dissipate this confusion. 
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3.1.1. Too many screening methods  
The difficulty of making decisions about the use of the best technology is partly 
owned to the great variety of the applicable screening methods. In the last three decades, 
the technological development concerning antenatal Down’s syndrome screening has been 
so enormous that currently 17-19 different screening strategies are available [70,71], which 
diversity of technical opportunities is without precedent in the other areas of medical care. 
The proliferation of methods has been fostered by the shift happened in the philosophy of 
screening as, while, in the 1980s and 1990s, single-type methods were used (either 
biochemistry or ultrasonography, and either first or second trimester tests), in the last 
decade complex screening methods have been introduced that apply biochemistry and 
ultrasonography together, or first and second trimester tests together. Thus, besides the 
well-known screening technologies, such as second trimester double, triple and quadruple 
biochemical tests and first trimester nuchal translucency scan [72-75], newer, complex 
screening technologies have slipped into practice (Table 2), such as the different versions 
of combined, integrated, stepwise sequential, and contingent screening [76-81], the 
advantages and disadvantages of which are not always evident for the practitioners. 
Table 2: Down’s syndrome screening tests and detection rates (5% screen positive rate) [82] 
First trimester Second trimester First and second trimester 
Screening test Detection rate Screening test Detection rate Screening test Detection rate 
NT measurement  64–70%* Triple screen 
(MSAFP, hCG, 
unconjugated oestriol)  
69%* Integrated  
(NT, PAPP-A, quad 
screen)  
94–96%* 
Combined screen 
(NT measurement, 
PAPP-A, free or total 
β-hCG)  
82–87%* Quadruple screen 
(MSAFP, hCG, 
unconjugated oestriol, 
inhibin A)  
81%* Serum integrated 
(PAPP-A, quad screen)  
85–88%* 
    
Stepwise sequential  
First-trimester test result 
after combined screen: 
- Positive: diagnostic test 
offered 
- Negative: second-
trimester test (quad 
screen) offered 
Final: risk assessment 
incorporates first and 
second results 
95%* 
    Contingent sequential  
First-trimester test result 
after combined screen: 
- Positive: diagnostic test 
offered 
- Negative: no further 
testing 
- Intermediate: second-
trimester test (quad 
screen) offered  
Final: risk assessment 
incorporates first and 
second results 
88–94%‡ 
Abbreviations: hCG = human chorionic gonadotropin; MSAFP = maternal serum alpha-foetoprotein; NT = nuchal 
translucency; PAPP-A = pregnancy-associated plasma protein A; quad = quadruple. 
*From the FASTER study [see reference 79] 
‡Modelled predicted detection rates [see reference 70]  
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3.1.2. Reliability of data on screening performances of tests 
Theoretically, the good screening performances of the complex methods, i.e. they 
have a high sensitivity (over 85%) and a low false positive rate (under 5%), can ease the 
task of choosing among them, as by their use, the number of detected Down’s syndrome 
pregnancies can be increased and the number of invasive diagnosis can be decreased. 
However, in the literature, doubts have emerged about the reliability of data produced by 
statistical models and observation studies. A great part of proposals on future screening 
policies have been based on statistical modelling studies using the data of well-designed 
trials, but critics have assumed that these tests would not perform so well in real world 
situation [83]. In practice, in cases of strategies containing two-step tests, the pregnant 
women’s participation in both parts of tests could not be totally ensured, however, it was 
presumed by modelling studies. Concerning observation studies, it has become clear that 
where nuchal translucency (NT) was measured only for the sake of scientific interest, the 
proportion of failed or unsatisfactory NT measurement was much larger than in 
intervention studies where NT was measured for the sake of risk calculation [75,84]. The 
confusion further increased when scientists conducting large-scale studies to compare the 
effectiveness of diverse screening methods made contradictory recommendations based on 
research data. For example, the leader of the British SURUSS study categorically opposed 
the introduction of contingent screening [85], while a representative of the North-American 
FASTER study definitely proposed it [45]. An additional ethical problem has been raised 
by conflicts of interests, e.g. when a screening technology has been patented (as it is the 
case with integrated test), since in this situation, personal prejudices may take part in 
proposals about the application of a particular screening technology.  
3.1.3. Issues of using biochemical or ultrasound screening, or both 
The new technologies have caused confusion not only by their surprisingly great 
number but also by their complex methods that have compelled professionals to change 
their previous ideas on screening. Scientific data, showing that combining biochemical 
screening with ultrasonography can give a better screening performance than either of the 
two tests alone [67], have challenged the views of those who have favoured the use of 
biochemical screening for the reason that serum tests are not so sensitive to professional 
skills than ultrasound scan [78]. As, except from serum integrated screening, all of the 
complex screening tests include nuchal translucency measurement, ensuring well-trained 
professionals who have acquired the skills necessary to perform this procedure is generally 
expected from recent prenatal screening services. While, previously, the concerns about the 
reliability of NT measurement have hindered the spread of nuchal translucency screening, 
nowadays, in the new screening programmes, these problems have been acknowledged and 
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initiations have been made to solve it by setting up standards for professional skills and 
ultrasound equipments, by organising specific training, and by establishing ongoing quality 
assessment of ultrasonographers and centres [82]. Noteworthy, that the Fetal Medicine 
Foundation, a registered charity organisation in the United Kingdom, has supported the 
appropriate introduction of NT screening into clinical practice for almost a decade, and has 
established a process of training and quality assurance, available through the Internet [86]. 
3.1.4. Issues of using first trimester or second trimester screening, or both 
The other professional attitude that has needed revision in light of new screening 
methods is the insistence on providing mainly second trimester tests. Second trimester 
triple and quadruple tests have been widely applied in the developed countries since the 
1990s. Recently, serum and fully integrated screenings, which integrate the results of first 
and second trimester tests into a single risk calculation [78], also support the idea of giving 
risk assessment only in the second trimester, by stating that fewer women have to decide 
about the future of a pregnancy because of the intrauterine loss of Down’s syndrome 
foetuses. However, in the existence of similarly effective first trimester screening methods, 
it is difficult to ethically justify the general use of methods giving risk assessment only in 
the second trimester, since they impede women in getting information earlier and in 
accessing to early diagnosis and early pregnancy termination. Empirical studies also 
suggest that pregnant women prefer first trimester screening, as, in a survey, about 70% of 
women stated that they would still choose first trimester screening even if all the identified 
Down’s syndrome pregnancies miscarried before the second trimester [87,88]. Moreover, 
telling nothing about the findings through ultrasound scan, and remaining silent when the 
probability of foetal abnormality is great, which are the expectations of integrated tests 
concerning the first trimester part of the tests, are unacceptable for many physicians. Some 
of these problems are solved by stepwise sequential and contingent screenings, which offer 
first trimester prenatal diagnosis for women in the high-risk group, but continue screening 
with all the remaining women or with women in the intermediate risk group. 
3.1.5. Issues of offering prenatal diagnosis on maternal age 
With the development of screening technologies, the importance of maternal age in 
antenatal Down’s syndrome screening has also been questioned, although, the association 
between maternal age and the risk of having a pregnancy with trisomy 21 (Table 3) has 
prompted a policy of offering prenatal diagnosis to pregnant women aged 35-37 years and 
more in the great majority of countries. In the 1970s, when this method was first applied, 
about 5% of pregnant women belonged to this age group who carried about 25-30% of 
Down’s syndrome pregnancies. By the application of screening methods providing 
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individual risk assessment, the significance of maternal age as a screening method has 
seemed to be decreasing. The risk calculated for an individual person gives more reliable 
information than a risk estimated for an age group, as, in the first case, the maternal age-
related and gestation-related risk is modified with the results of the performed screening 
tests. However, until now, only the American College of Obstetricians and Gynecologists 
recommended in 2007 to cease proposing automatically prenatal diagnosis to pregnant 
woman aged 35 years or more and to offer invasive diagnosis only on the results of tests 
providing individual risk calculation or at the request of the pregnant woman [82]. 
Nonetheless, the latest changes in the age distribution of pregnant women has drawn 
attention to the need of cautious decision-making on the role of maternal age in prenatal 
Down’s syndrome screening. In the well-developed countries, the proportion of pregnant 
women aged 35 years and more is around 15-20%, so, the sensitivity of screening based on 
maternal age reaches 50-60% in those countries [10,89].  
Table 3: Estimated risk for trisomy 21 in relation to maternal age and gestation [75] 
Maternal 
age (yrs) 
Gestation (wks)  Maternal 
age (yrs) 
Gestation (wks) 
 12 16 20 40   12 16 20 40  
20 1068 1200 1295 1527  35 249 280 302 356 
25 946 1062 1147 1352  36 196 220 238 280 
30 626 703 759 895  37 152 171 185 218 
31 543 610 658 776  38 117 131 142 167 
32 461 518 559 659  39 89 100 108 128 
33 383 430 464 547  40 68 76 82 97 
34 312 280 378 446  41 51 57 62 73 
(Rate of foetal loss is about 30% between 12 weeks of gestation and term, and about 20% between 16 weeks and term) 
3.2. Need for professional guidelines on screening technology 
In answering the question what screening method should be used, the professional 
bodies of prenatal screening experts, obstetricians, and geneticists have fundamental 
responsibilities, since their statements can function as guidelines for national screening 
programmes, for private health care services, and even for pregnant women. The 
construction of professional guidelines can be supported by a summary of requirements 
that screening programmes have to meet according to the findings of the above analysis: 
− Based on reliable data: Screening strategies should be built on the results of large-scale 
prospective and intervention studies to avoid biases connected to research methodology. 
− Presenting good screening performance: Of the available methods, those should be 
used that perform a high detection rate (over 85%) and a low false positive rate (5% or 
less). With the decrease of false positive and false negative test results, maternal anxiety 
and the number of invasive diagnostic procedures can be reduced. 
− Combining biochemistry with ultrasonography: According to data, this combined 
technology is one of the most effective ways of reaching good screening performance. 
Including first trimester combined screening (NT, PAPP-A, free β-hCG) in the 
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screening strategy should be considered. However, since obtaining nuchal translucency 
measurement necessitates specialised training, and nuchal translucency might not be 
measured successfully in an individual patient, besides combined screening, other 
methods should also be made available.  
− Offering first trimester screening: This option can shorten the period of “tentative 
pregnancy” and maternal anxiety, can ensure early diagnosis, and can fulfil the 
preferences of the majority of pregnant women. Of the complex methods, not only the 
combined test but also some contingent methods make possible to complete screening 
in the first trimester even for women in the intermediate risk group [81]. 
− Offering also second trimester screening: To maintain this type of screening is 
necessary in the interests of pregnant women seeking prenatal care only in the second 
trimester. Quadruple test (AFP, hCG, oestriol, inhibin-A) is unanimously accepted as 
the best second trimester test for Down’s syndrome. 
− Requiring the audit of screening professionals and centres: Where screening 
programmes include nuchal translucency measurement, specific training to acquire a 
standardised method of measurement and ongoing quality control are recommended. 
− Taking a stance on the role of maternal age as a screening method: In this process, 
besides the age distribution of pregnant women, the wide public awareness about the 
increased risk of women aged 35 years or more should be taken into consideration.  
− Addressing counselling issues: Counselling issues are especially important in cases of 
those complex methods where risk is calculated only after the full completion of tests. 
− Considering cost-effectiveness: Some authors include the cost of care of people with 
Down’s syndrome in the cost of prenatal screening [45], however the acceptability of 
this policy is debated as prevention cannot function as an ethically justifiable aim.  
In summary, because of the ethical requirements of enhancing reproductive 
autonomy and considering foetal safety, those methods should be offered that give 
individual risk assessment, present high sensitivity (85% or more) and low false positive 
rate (5% or less), and their results are confirmed by large observation studies. Since not 
only one but some methods can meet the requirements, through screening, local conditions 
(number of well-trained sonographers and accredited laboratories, financial limitations), 
and specific needs deriving from gestational age, number of foetuses, previous obstetric 
history, or wishes to finish the test in the first trimester can be taken into account [90]. To 
dissipate uncertainty on the use of screening methods, I propose that professional bodies 
should clearly define what technology can fulfil best the given medical, ethical or 
economic requirements and that screening professionals should openly disclose pregnant 
women the reasons on which the use of a particular method is based.  
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4. Role of comprehensive and personalised information in 
enhancing parents’ reproductive autonomy 
When screening professionals disclose the considerations underlying the use of a 
particular screening method, they support the idea of giving comprehensive information on 
prenatal Down’s syndrome screening that is required by the aim of promoting parents’ 
reproductive autonomy. Detailed information can help women and couples in performing 
the following tasks: (1) deciding about the participation in screening, (2) understanding the 
test results and their consequences on the baby’s health, and (3) deciding about the course 
of action to follow after screen positive results. In the accomplishment of these activities, 
pre-test and post-test information can provide effective support for the majority of parents, 
but in cases of increased risk, genetic counselling is also required. In this chapter, the 
factors influencing the provision of pre- and post-test information are examined.  
4.1. Pre-test information  
Informing the candidates of genetic screening programmes is considered so 
fundamental that the EuroGentest, a network of excellence funded by the European Union, 
recommends not implementing a screening programme if comprehensive and well-planned 
pre-test information and counselling are not guaranteed [91]. The special problems of 
prenatal Down’s syndrome screening, namely, that screen positive results may increase 
maternal anxiety, may result in risky diagnostic procedures performed on healthy foetuses, 
and may force women to make reproductive decisions about the continuation or the 
termination of their pregnancies, justify the demand of providing women detailed 
information prior to screening. If screening is offered as a routine part of care, or is 
performed without the consent of pregnant women - both types of conduct neglect the 
provision of comprehensive information - women and couples do not have the opportunity 
to prepare for the consequences of screening. 
4.1.1. Factors influencing information giving: attitudes of pregnant women and 
medical professionals to screening 
The interpretive ethics approach illuminates that the effectiveness of information 
giving, meaning, the information is perceived by pregnant women and then used up in their 
decision-making, requires not only providing detailed information but also adjusting 
information to the individual needs of women [31]. The interpretive approach also 
highlights that the presumptions and experiences of health care professionals influence 
remarkably the patient-professional interaction [35]. Therefore, exploring the attitudes of 
pregnant women and medical professionals to prenatal Down’s syndrome screening seems 
indispensable for ensuring the success of the information process. After reviewing 
literature data by the interpretive method, a brief overview of the most frequently 
mentioned contextual factors has been constructed. 
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Table 4: Women’s attitudes influencing information perception on prenatal Down’s syndrome screening 
Attitudes of women Characteristics of attitudes Communication measures to overcome 
the negative effects of attitudes 
Compliant behaviour 
− Behaviour, on that basis, every medical 
procedure offered by a professional is 
accepted in order to ensure the baby’s health. 
However, this behaviour does not promote 
thoughtful decision-making about the 
acceptance of screening [40] 
− Those aspects of screening should be 
emphasised that differentiate screening from 
routine medical procedures.  
− Attention should be drawn to both the 
advantages and disadvantages of screening. 
Beliefs about the aim 
of screening 
− Women believe that the aim of screening is 
detecting foetal anomalies in general, but it is 
giving reassurance in their own cases [92]. 
− Emphasising the aim of screening before the 
beginning of examinations and giving data 
about the recall rate may help women 
prepare for both screen negative and screen 
positive results. 
Pursuing non-medical 
aims  
− Some women assess ultrasound screening as 
a “nice baby watching” and not as a tool to 
search for abnormalities [93]. 
− Before ultrasound examination, the 
alternative outcomes of reassurance and of 
detecting anomalies should be disclosed. 
Emotional reactions 
to screening 
− Even the offer of screening can cause 
maternal anxiety [94,95]. 
− Ultrasound screening can strengthen 
emotional bond between mothers and 
foetuses, which turns decision-making about 
the future of an affected pregnancy 
troublesome [96].  
− Screen positive results cause maternal 
anxiety [97].  
− Giving all the relevant information prior to 
screening is a general expectation as in this 
period, women are not so anxious and can 
think over the consequences of screening 
more carefully than after the disclosure of 
screen positive results. 
Lack of knowledge on 
Down’s syndrome 
− Women underestimate the prevalence of 
Down’s syndrome, and know little about the 
impacts of the disorder [98]. 
− Information should be provided not only 
about the medical aspects but also about, 
the educational and social impacts of Down’s 
syndrome. 
Difficulty in 
understanding the 
concept of risk 
− Women often find difficult to distinguish 
screening from diagnosis [99] and to 
understand the concept of risk calculation 
[100,101]. 
− Prenatal screening can be compared to 
other, better known screenings. 
− Visual interpretation can be useful for 
interpreting the meaning of risk.  
Table 5: Professionals’ attitudes influencing information giving on prenatal Down’s syndrome screening 
Attitudes of medical 
professionals 
Characteristics of attitudes Measures to overcome the negative 
effects of attitudes 
Biased attitude to 
screening 
− Some physicians show biased attitude to 
screening because of their opposition to 
abortion [39]. 
− Professionals should acknowledge that based 
on their personal values, they can refuse to 
perform abortion but cannot refuse to give 
women information about the availability of 
screening. 
Offering screening as 
routine 
− Screening is offered as routine, no pre-test 
counselling is provided. This practice is 
generally justified by lack of time [94,99] 
− Information constitutes an essential part of 
screening. Time should be guaranteed for 
giving information.  
Uncertainty about the 
appropriate screening 
method 
− The multitudinous, currently available 
screening strategies have resulted in 
confusion among practitioners [82].  
− Guidelines constructed by professional 
bodies can help practitioners choose the 
appropriate method. 
Favouring a particular 
screening technology 
or strategy 
− Screening is offered only for women aged 
35 years or more [102,103]. 
− Among practitioners, sometimes, an 
unjustified insistence on either 
ultrasonography or biochemistry can be 
recognised.  
− National screening programmes and private 
practitioners are expected to revise their 
screening policy regularly in order to avoid 
the use of outdated screening methods. 
− Professional guidelines can help this process. 
− The reasons underlying the use of a 
screening method (medical, economic, 
others) should be disclosed. 
Unbalanced 
information on lives of 
people with Down’s 
syndrome 
− Counselling may be unduly negative about 
the likely quality of life for people with 
Down’s syndrome [104,105]. 
− Providing women up-to-date information 
about the life of people with Down’s 
syndrome is deemed important in facilitating 
informed choice.  
− A co-operation with parent support groups 
can help professionals to get reliable 
information. 
Communication 
difficulties 
− Communication difficulties arising from a 
largely different cultural background of the 
patient and the professional may 
compromise the effectiveness of 
information giving [106]. 
− Not only the technical skills but also the 
communication skills should be taught to 
providers of screening tests. 
− Communication training should be involved in 
their continuous education. 
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4.1.2. Contents of pre-test information 
The acknowledgement of the socially, culturally, and emotionally determined 
attitudes can assist a carefully planned information process, and can successfully serve the 
basic idea of interpretive ethics that the content of pre-test information should be directed 
by the needs of pregnant women and not by the expectations of the professionals [107]. In 
the following, a guideline is presented that can promote public and private screening 
services in giving adequate written and verbal information on the following issues [108]: 
Addressing the aim of prenatal Down’s syndrome screening: In accordance with 
ethics, the aim of screening should be considered as informing the parents about the chance 
of having a Down’s syndrome pregnancy. The parents’ attention should be drawn to the 
scenario that screening might be followed by decision about the future of the pregnancy; 
therefore, it is advisable to make thoughtful decision about the participation in screening. 
Ensuring respect for parents’ autonomy: Pregnant women and their partners should 
be informed that prenatal testing is voluntary; before screening, pregnant women’s 
informed consent should be obtained. The whole screening process or any steps of it can be 
refused. Women and couples must not be subjected to pressure to undertake the test, to 
terminate a pregnancy, or to make decisions in undue haste [109,110]. 
Description of the screened disorder: Comprehensive and balanced information 
about the medical, educational and social impacts of Down’s syndrome should be given, 
which includes data about community-based services, early intervention programmes and 
opportunities for integrated life [111]. In these questions, the experiences of parent support 
groups can be taken into account. Outdated information, negative stereotypes, or offensive 
terminology concerning life with Down’s syndrome should be excluded. 
Practical aspects of screening: Information involves the date of screening, e.g. in 
what week of pregnancy the test is performed, and screening includes one-step or two-step 
tests. The method of screening should also be disclosed, e.g. what kind of biochemical 
and/or ultrasound markers are examined, and what their values are in unaffected and in 
affected pregnancies. A brief explanation must be given on the procedure of individual risk 
calculation, and women should be informed about when and how screening results are 
disclosed. [98,109,112]. 
Epidemiological data of screening: Using understandable epidemiological 
terminology and giving comprehensible information on screening performances of tests are 
difficult, however, are important. These data can influence women’s decisions about the 
uptake of screening and can prevent women from overestimating or underestimating the 
potentials of screening. Epidemiological information should embrace the frequency of 
Down’s syndrome both in pregnancies and in live births, the differences of screening and 
diagnosis, the arbitrary nature of cut-off risk, the meaning of screen positive and screen 
negative results, and the possibility and reasons of false positive and false negative 
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screening results. On screening performances of tests - including detection rate, recall rate 
and false negative rate - better to give centre-specific data, if they are available. 
Consequences of screening: Deciding about the acceptance of diagnostic tests 
offered after screen positive results is one of the most significant consequences of 
screening. Thus, women should get information about the diagnostic methods and their 
risks, and about the length of time, they should wait to get the result of the diagnosis. 
Women should also be informed about the availability of genetic counselling where they 
can get support in the interpretation of screen positive results and in decision-making about 
prenatal diagnosis or the future of the pregnancy. It should be disclosed that respecting the 
parents’ decisions about the continuation or the termination of an affected pregnancy is 
ethically required. It is also advisable to mention the psychological impacts of screening, 
since even the offer of screening can increase maternal anxiety, and screen positive results 
affect negatively the psychological well-being of women, regardless how the information 
is presented. Addressing the name of a professional who can give advice in case of anxiety 
is useful for both screening programmes and private services [107,113-115]. 
Evaluation of screening: Summarising the advantages and disadvantages of a 
particular screening test, comparing its screening performance to that of other tests, and 
revealing the reasons why this particular test is offered can fulfil the expectation of giving 
balanced information and can facilitate parents’ careful decision-making.  
Resources to get further information: Offering information leaflets, newspaper 
articles, and reliable Internet addresses can help women to get further information [39]. 
In literature, the combination of information leaflets and personal communication is 
endorsed as the best form of pre-test information [116-118]. A readable, regularly updated 
information leaflet can be taken home where enough time is ensured to think over the 
impacts of screening. Personal communication can tailor information to individual needs. 
4.2. Post-test information  
Post-test information differs from genetic counselling, since the first is provided by 
a screening professional to every woman participating in prenatal screening, while the 
second is provided by a specially trained genetic counsellor to only a group of women who 
are assessed as having a high-risk pregnancy.  
4.2.1. Risk presentation 
Disclosing risk constitutes one of the most important parts of post-test information, 
and data suggest that screening results can be more effectively conveyed through personal 
communication than through phone or letter [98]. In connection to risk communication, the 
aspects of interpretation should be taken into account, as, for example, the parents of 
children with Down’s syndrome have proposed the use of the word “chance” instead of 
“risk”, as in their views, the meaning of chance is neutral, however, the meaning of risk is 
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negative [119]. Another debate addresses the dilemma whether words, numbers, or both 
should be applied when probability information is disclosed to patients. Concerning the 
results of prenatal Down’s syndrome screening, the most preferred expressions are: screen 
positive - screen negative, increased risk - decreased risk, or requiring further tests - not 
requiring further test. When screening results are expressed in numbers, fractions (1/250, 
1:250) or percentages (0.4%) are used. Fractions or percentages should be consistently 
applied as it can be misleading if the screening result is given in the form of fraction and 
the risk of amniocentesis-related miscarriage is given in the form of percentage [120]. 
Although many physicians believe that words are easier to process, many others think that 
numbers may increase awareness of residual risks and may encourage deliberative 
decision-making [121]. According to an additional professional opinion, numbers alone are 
not enough; their meaning should be interpreted by words [122]. It is also admitted that 
information about the arbitrary nature of cut-off level of risk promotes thoughtful decision-
making, therefore, parent can be given the example that the risk 1:300 counts high in one 
country but not high in another [123]. The idea of giving balanced information can be 
served well by framing risk in both terms of loss and gain, e.g. “You have 10% chance of 
having an affected baby, or you have 90% chance of having an unaffected baby.” [124]. 
4.2.2. Risk perception 
The aspects of interpretation appear in risk perception as well, which is determined 
by more complex factors than only risk presentation. For example, reasoning methods have 
an effect on risk perception; the same risk, if it is expressed variously as a percentage or a 
fraction, is understood differently according to whether the patient uses numerical 
reasoning, e.g. numbers serve as anchoring points, or person reasoning, e.g. numbers 
function as representatives of persons [125]. Assessing the comprehension of women more 
frequently may facilitate more effective risk communication. Besides the probability of 
outcomes, risk perception is also influenced by the value the parents attach to the outcomes 
and by the opinion the parents hold about the seriousness of the disease. Literature has 
drawn attention that perceived risk, rather than the communicated risk, predicts pregnant 
women’s medical decisions [121]. Consequently, discussion about risk should be a two-
way exchange of information. Simply providing risk information without discussing the 
pregnant women’ circumstances and perceptions does not help make informed choices. 
In summary, giving information constitutes an essential part of screening for which 
time and financial resources should be guaranteed. Because of the essential role that 
comprehensive information plays in decision-making, an information leaflet should be 
given to all women prior to screening and communication training should be included in 
the post-graduate education of screening professionals, where the data of tests and the 
ways of giving information on risk are taught. Where prenatal screening lacks central co-
ordination, relevant professional organisations can help physicians acquire these skills.  
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5. Genetic counselling relationship of counsellors and women 
with an increased chance of having an affected pregnancy 
When prenatal screening results refer to an increased chance of having a Down’s 
syndrome pregnancy, or when a pregnant woman is aged 35-37 years or more, or when she 
had an affected pregnancy previously or has a positive diagnostic result now, genetic 
counselling is offered to help her make informed decision. Over the last decades, the 
notion of non-directiveness has governed the ideal genetic counselling relationship of 
counsellors and clients. In the sense of non-directiveness, genetic counsellors are expected 
to give “objective”, value-neutral information on the genetic risk, the genetic disorder, and 
the available screening, diagnostic and treatment possibilities [126-128], and they are also 
expected to refrain from offering advice in value-laden problems, e.g. pregnancy 
termination, acceptance of diagnostic procedures carrying the risk of pregnancy loss [129]. 
However, recently, studies have highlighted that it is impossible to provide neutral 
information, since genetic facts may not be insulated from social, professional, and 
personal values [130-132]. Additionally, experience with genetic counselling has revealed 
that an impartial communication style often hinders counsellees in gaining adequate 
information and in perceiving the problem [133-135].  
As these new ideas have illuminated that the individual value orientations of 
counsellors exert an indispensable influence over the course of counselling, and that 
without the fulfilment of counsellees’ expectations, the counselling process may prove to 
be useless, I thought demanding to examine the everyday practice of genetic counselling in 
Hungary. Thus, by an ethical analysis of the relevant literature, the views of counsellors on 
the goal of genetic consultation were studied, and by an empirical research, the genetic 
counselling expectations of counsellees were explored [36]. The results of these studies 
were expected to answer the questions that besides non-directive genetic counselling, what 
kind of methods were practiced by counsellors, and what kind of counselling style could 
fulfil the expectations of counsellees.  
5.1. Views of counsellors on the goal of reproductive genetic counselling 
Although, in Hungary, the professional body of clinical geneticists has given an 
official statement on the goal of genetic counselling [136], other definitions have also 
survived that have been constructed since the 1970s, when a wider spread of these services 
began. 
5.1.1. Preventing diseases—an information guidance approach 
The approach that dominated the 1970s and 1980s and has remained recognisable 
even in today’s counselling practice was introduced by Endre Czeizel, who defined the 
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goal of genetic counselling as to prevent severe diseases and to promote the birth of 
healthy children in the interests of families and society [137]. To achieve this aim, the so-
called information guidance approach was applied; counsellors made unsolicited 
recommendations to parents on reproductive decisions, e.g. to undertake a pregnancy or to 
refrain from it because of the high genetic risk to the foetus [138]. The application of the 
nondirective counselling method was rejected, since counsellors believed that it did not fit 
the Hungarian medical context. They thought that clients needed direct advice on what to 
do. Although accepting the offered solution was not mandatory [139], the information 
guidance approach was criticised on international forums for its features of violating the 
reproductive autonomy of the parents. Owing to the criticism, the overt support of this 
approach became inconvenient by the second half of the 1980s, nevertheless, sometimes 
reports have been heard even today about counsellors giving selected information and 
recommending the prevention of birth defects without the clients’ request for advice.  
5.1.2. Preventing diseases and respecting reproductive autonomy—a transitory approach  
The next approach, invented in the early 1990s and having been favoured from that 
time, supports the adoption of the non-directive method. Zoltán Papp, the main advocate of 
this view, has emphasised that in a non-directive counselling relationship, the counsellor’s 
tasks include providing information and advice, but do not involve decision-making [140]. 
By its moral standpoint, that the right to decide about the future of a pregnancy belongs 
solely to the parents, this view has contributed to the abandonment of recommending 
parents a particular course of action. The commitment to the respect for the parents’ 
reproductive liberty, however, has not been reflected in the definition concerning the goal 
of genetic counselling, since Z. Papp has assumed that the aim of counselling is to ensure 
the birth of a healthy child for families at high genetic risk [141]. Nonetheless, this 
transitory view of combining the goal of respecting the autonomy of counsellees with the 
goal of disease prevention involves an essential contradiction. While the promotion of the 
autonomous choice of counsellees requires the provision of balanced information, the goal 
of prevention constrains parents’ free choice as the information disclosed is permeated 
with the counsellor’s personal view about the importance of preventing diseases. The focus 
on prevention limits the counselling interaction as well, since it does not encourage the 
recognition of the parents’ needs differing from disease prevention, such as understanding 
probability information, or finding coping strategies for the situation of being at risk. 
5.1.3. Enhancing the autonomous choice of parents—an informative approach  
From the beginning of the 1990s, another type of genetic counselling practice has 
also been prevalent in the country, the goal and method of which unambiguously 
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correspond to the ethical norms of non-directiveness. The proponents of this type of 
approach, e.g. Olga Török, Csaba Papp, and Ernı Tóth-Pál, have considered reproductive 
genetic counselling as being fundamentally a communication process involving informing 
and educating parents to make family planning decisions [53,142]. They have omitted the 
prevention of diseases from the goal of genetic consultation, and have restored the original 
meaning of non-directiveness by demanding from the counsellors not only to allow parents 
to make choices, but also to ensure the impartiality of information on which parents base 
their decision. This approach has also tried to restrict the possibility of imposing the values 
of the counsellors on the clients; thus, counsellors have been expected to abstain from 
proposing a solution, but, on exceptional occasions, they have been allowed to inform 
clients about what the majority of parents decided in the same situation [143].  
5.1.4. Enhancing the careful deliberation of parents—an interpretive approach  
In recent years, a concept has been espoused by me and a colleague [144] that the 
goal of genetic counselling should be shifted from giving impartial information to the 
promotion of the careful deliberation of counsellees. This aim takes into account the 
philosophical consensus on the impossibility of value neutrality; and in order to help 
counsellees reach well-informed and well-considered decisions, it demands from the 
counsellor not only to give counsellees detailed medical information but also to explore 
their values with considerable effects on their decision [145,146]. To accomplish this duty, 
the so-called interpretive counselling method has been proposed, which provides a useful 
aid in identifying the value orientations of the counsellor, the counsellee, and the 
community that are relevant in the counselling interaction [38]. Through open dialogue, in 
which the counsellor does not dominate, the counsellor and the counsellee can discuss facts 
and value-laden problems as well, and finally, they can find a solution that is acceptable to 
the counsellee. Similar to the non-directive view, the interpretive counselling approach 
emphasises that forcing a particular decision on the counsellee is impermissible; thus, the 
non-prescriptive communication style remains the basic feature of genetic consultation. 
5.2. Genetic counselling expectations of counsellees 
After a review of the genetic counsellors’ views, the counsellees’ expectations were 
studied and to gain data on this issue, pregnant women attending the genetic counselling 
clinic in Szeged, Hungary between September and December 2006 were asked to answer a 
questionnaire containing 21 items. The study was approved by the institutional ethics 
committee. Of the 181 eligible participants 170 responded (response rate 94%), and prior 
to counselling, the following data were collected (Table 6): 
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Table 6: Sociodemographic and health-related characteristics of the respondents (n = 170)* 
 n (%) 
Age    
− 19-24 years 9 (5) 
− 25-29 years 24 (14) 
− 30-34 years 46 (27) 
− 35-39 years 76 (45) 
− 40 years and above 15 (9) 
Residence    
− Village 43 (25) 
− Small town 77 (46) 
− City 49 (29) 
Education    
− Primary school 24 (14) 
− Secondary school 89 (53) 
− College/university 55 (33) 
 
 n (%) 
Previous pregnancies    
− 0 50 (29) 
− 1 57 (34) 
− 2 or more 63 (37) 
Previous counselling experience    
− Yes 47 (28) 
− No 123 (72) 
Reasons for counselling    
− Maternal age ≥35 years 89 (53) 
− Positive screening test 23 (14) 
− Previous genetic anomaly 16 (9) 
− Drug or environmental exposure 41 (24) 
Participants of counselling    
− Pregnant woman alone 78 (46) 
− Pregnant woman with partner 75 (44) 
− Pregnant woman with family member 17 (10) 
 
* Numbers do not all sum to 170 because not all respondents answered all the questions. 
Pre-counselling, the counsellees’ expectations on medical information, psychological 
support, types of decision-making, and possible decisional aids of knowing the decisions of 
other parents and the opinion of the counsellor were also inquired. Post counselling, the 
respondents were asked to evaluate the effect of actual genetic counselling from the 
viewpoints of comprehensiveness of information, the calming effect of psychological 
support, the types of their actual decision, and their satisfaction with the overall process of 
counselling. Statistical analysis was performed by the Statistical Package for Social 
Sciences, version 15.0 (SPSS, Chicago, IL, USA). The Chi-squared test was used to search 
the correlations of expectations, the fulfilment of expectations, the actual decision-making, 
and the satisfaction with the overall process of counselling with the characteristics of the 
respondents and with one and other. P ≤ 0.05 was considered statistically significant. 
5.2.1. Pre-counselling expectations of counsellees 
Prior to counselling, the majority of women wished to receive detailed and new 
information, to get psychological support, and to know the counsellor’s opinion (Table 7).  
Table 7: Counsellees’ expectations on genetic counselling  
Counsellees n=170 Expectations 
n (%) 
Detailed information 167 (98) 
New information 140 (82) 
Psychological support 115 (68) 
To know the decisions of other parents 77 (45) 
To know the counsellor’s opinion 119 (70) 
Shared decision-making 106 (62) 
Independent decision-making 56 (30) 
Counsellor’s decision-making 10 (6) 
Wishing to know the counsellor’s opinion presented a direct connection with the reason for 
counselling (p = 0.051), with education (p = 0.032) and with the number of previous 
pregnancies (p = 0.019), since women who had screen positive results, or who were 
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pregnant with their first baby, or who had a college or university degree expected more 
frequently the counsellor’s advice than the others. Answers concerning the expected type 
of decision-making showed that 62% of the counsellees intended to rely on the 
counsellor’s support and wanted to reach a shared decision, 6% expected the counsellor to 
make the decision on their behalf, and 30% insisted on an independent decision. Of the 
sociodemographic variables, only education presented a statistically significant 
relationship with the expected type of decision-making (p = 0.026). Pregnant women with 
college or university degrees expected a shared decision, while respondents with a lower 
level of education expected an independent decision more frequently than the others. 
5.2.2. Impacts of expectations and their fulfilment on actual decision-making 
According to the reports of the counsellees, 45% of the consultations resulted in 
shared decisions, 35% in independent decisions, and no decision was reached in 20% of 
the cases (Table 8). In the study, women did not report the counsellor’s decision-making.  
Table 8: Evaluation of actual decision-making 
 Total 
 
 
n=170 
Shared 
decision was 
made  
n=76 
Independent 
decision was 
made 
n=60 
No decision 
was made 
 
n=34 
 
 n (%) n (%) n (%) n (%) p value 
Education         0.072 
− Primary school 24* (14) 12* (16) 10* (17) 2 (6)  
− Secondary school    89 (53)    38 (51)    36 (61) 15 (44)  
− College/university    55 (33)    25 (33)    13 (22) 17 (50)  
Expected type of decision-making          <0.001 
− Shared 106 (62) 61 (80) 22 (36) 23 (68)  
− Independent 51 (30) 6 (8) 36 (60) 9 (26)  
− Counsellor’s 10 (6) 7 (9) 1 (2) 2 (6)  
− Uncertain  3 (2) 2 (3) 1 (2) 0 (0)  
Expecting to know other parents’ decision 77 (45) 33 (43) 26 (43) 18 (53) 0.606 
Expecting to know the counsellor’s opinion 119 (70) 56 (74) 37 (62) 26 (76) 0.263 
Unanswered questions have remained 9 (5) 2 (3) 2 (3) 5 (15) 0.024 
Calming affect of consultation 110 (64) 56 (74) 38 (63) 16 (47) 0.025 
Overall satisfaction with counselling 160 (94) 72 (95) 57 (95) 31 (91) 0.730 
* Numbers in the column do not sum to the total because not all respondents answered the question about education. 
Expectations on the type of decision-making strongly affected the actual shared or 
independent decisions, as 80% and 60% of them respectively followed the expected type. 
Wishes associated with the mode of decision-making, however, did not influence the 
success of resolution, since the proportion of consultations that failed to agree on a 
decision was almost the same for each expected type of decision-making, and varied 
between 18 and 22%. As the possibility of getting to know the other parents’ decisions and 
the counsellor’s opinion was hypothetical, we were able to examine the impacts of these 
expectations, but not those of their fulfilment on decision-making. Data showed that the 
proportion of women wanting to know the preferences of other parents and of the 
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counsellor was greater in the group that did not reach a decision than in the other groups, 
though this difference was not significant statistically. 
The evaluation of actual genetic counselling has explored that statistically 
significant correlations were found between the satisfaction with information and 
psychological support, and the result of the decision-making process (Table 8). According 
to the analysis, in the group with unsuccessful resolution, the proportion of women who 
had unanswered questions was higher, and the proportion of those who felt the calming 
effect of genetic counselling was lower than in the groups with successful resolution. 
Education affected with borderline significance the type and success of the actual decision. 
Among women with a college or university degree, the frequency of independent decisions 
was lower, and the frequency of not reaching a decision at all was higher than among 
women with a lower level of education. The satisfaction with the overall process of the 
consultation was high, independent of the type and success of resolution. Only the failure 
to answer all the counsellee’s questions correlated significantly with the overall 
satisfaction (p = 0.008), and had a negative effect on it. 
5.2.3. Evaluating the expectations of counsellees and comparing them with the views of 
counsellors 
Similar to studies conducted in Western countries, in our study the respondents 
have perceived the tasks of genetic consultations as not only to give comprehensive 
information, but also to provide psychological support and to facilitate decision-making 
[147,148]. Of the counselling types, the information guidance, the transitory, and the 
informative approaches have not received wide support. The counsellor’s decision-making, 
the essence of the information guidance approach, was almost unanimously rejected 
(92%), and the majority of women intended to take part in the resolution process. Contrary 
to the transitory view, counsellees wanted more help than just information about the 
options of preventing diseases, e.g. they expected psychological support (68%). The 
appropriateness of non-directive counselling, the guiding idea of the informative approach, 
was questioned by those counsellees who wished to know the counsellor’s preference 
about the course of action to follow (70%). The usefulness of neutral communication was 
also challenged, since the counsellees’ successful decision-making required a type of 
consultation in which information and psychological support were tailored to the 
counsellees’ individual needs, as in opposite cases the decision-making was postponed. 
Compared with a study conducted in the UK in which 30% of counsellees expected 
help in making decisions [149], in our study this ratio was 68%. The extensive need for the 
counsellor’s involvement in the decision-making has illuminated the women’s uncertainty 
about the process of resolution, behind which the lack of knowledge or the wish to share 
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the responsibility of decision-making with the counsellor may be found [150]. However, in 
Hungary the lack of deep traditions concerning the autonomous decision-making of 
patients has also played an important role in the clients’ behaviour of refraining from 
independent decision-making. Deriving from this circumstance, in our country the role of 
the counsellor in the independent and well-considered decision-making of the counsellee is 
more essential than in countries with old democratic traditions. The importance of the 
counsellor’s activity in the process of resolution has been reflected in the data reporting 
that counsellees were apt to modify their preconception, and that they could even reach an 
independent decision as a result of the consultation (40% of the independent decisions 
were made in this way). The proportion of highly educated women expecting and making 
shared decisions reassured the findings of Wertz and Sorenson [151], which demonstrated 
that counsellees with higher education reported more frequently the counsellor’s influence 
on their decision than clients with lower education. Data suggest that better educated 
women appreciate highly the counsellor’s professional knowledge and can better utilise the 
information provided them. However, according to our research, the supposedly greater 
knowledge led to greater uncertainty as well, since the ratio of highly educated women 
reaching no decision was above that of groups with lower education.  
5.2.4. Characteristics of genetic counselling meeting the expectations of counsellees 
The results of the study have given support to the kind of counselling method that 
adjusts professional help to the individual needs of the counsellees, allows the counsellor 
to play an active role in the course of decision-making, and excludes the dominance of the 
counsellor. Of the approaches promoted by genetic professionals, the interpretive 
counselling approach promises fulfilment of these requirements. As this method requires 
the counsellor to understand the counsellee’s particular situation, the counsellee’s 
individual wishes can be recognised and responded to, which could be especially useful for 
those women who remained uncertain about the decision after the consultation. The 
dialogical relationship, the main characteristic of the interpretive method, gives the 
counsellor the opportunity to distinguish cases in which the independent decision of the 
counsellee is a realistic option from those in which more help is necessary and shared 
decision-making should be aimed for. The application of the interpretive method allows 
the counsellor to disclose her opinion as well, which was expected by the majority of the 
respondents. This action would not encourage the revival of paternalism, since, in the 
interpretive counselling relationship, the values of the participating parties are explored 
and openly discussed, which can serve as a guarantee of finding a proposal that 
corresponds with the values of the counsellee and not with those of the counsellor. 
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6. Method of interpretive genetic counselling promoting the 
careful decision-making of counsellees 
The results of our study on the counsellees’ expectations have strengthened the 
views of those who have demanded the implementation of new consultation methods that 
differ from the non-directive approach. It has also been revealed that counsellors should 
gain understanding about the situation of counsellees in order to help them reach well-
informed and well-considered decision. As in human understanding, besides psychological 
rules, philosophical characteristics play an essential role, I contend that the theory of 
interpretation, being explicated by Hans-Georg Gadamer in his book, Truth and Method, 
offers physicians an aid to reach the true understanding of counsellees and to facilitate their 
decision [33]. Since V. Árnason systematised the Gadamerian concept according to the 
aspects of the patient-professional interaction, his views were used when I and a colleague 
were elaborating the methodological framework of interpretive genetic counselling [35], 
which could assist counsellors to incorporate the interpretative approach into their practice. 
6.1. The Gadamerian four-openness model of interpretation 
Summarising Gadamer’s theory on interpretation, Árnason has asserted that during 
dialogues four aspects of openness are necessary to understand the other and to take 
seriously her claims, such as openness to oneself, openness to the other, openness to the 
subject matter, and openness to tradition [33,35].  
Openness to oneself: In Gadamer’s view, during the process of understanding we 
all use our prejudgements and anticipations to project some meaning to the text, to the 
situation or to the person as a whole. These various cultural, personal or theoretical 
presuppositions constitute our horizons, without which any human understanding would 
not be possible. Openness to oneself requires the acknowledgement of these prejudices, 
and by this type of openness, dogmatic thinking may be escaped.  
Openness to the other: This phenomenon means the listening to the other person 
and the perception of her difference. Gadamer has pointed out that the method of objective 
observation does not help us to recognise the differences of the other, since, if we remain 
emotionally unaffected, we can grasp only the typical features of the other person and we 
fail to take into consideration her subjectivity. It also does not lead to true understanding 
but only to the domination of the interpreter’s perspective if the interpreter believes that 
she understands the other person better than the other understands herself. Gadamer has 
asserted that, as we are not able to fully comprehend the other, the best an understanding 
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person can do is to think with the other and to undergo the situation with her. In dialogues, 
the interpreter puts at risk her prejudices and is willing to accept the opinion of the other. 
Openness to the subject matter: This idea reveals that during open dialogues, 
partners let themselves be conducted by the subject matter of the conversation and their 
dialogue is exclusively governed by the dialectic of questions and answers concerning the 
topic. Gadamer has drawn our attention to the role of questions in the process of 
understanding, stating that the act of asking questions expresses both the interpreter’s 
awareness of the limitation of her perspective and her real interest in the opinion of the 
other. This attitude can generate the “fusion of horizons”, and by the end of the 
conversation, partners can form an agreement on the situation, differing from the 
prejudgements of both of them. 
Openness to tradition: This idea contains the notion that we should be conscious of 
our historical affectedness, which indicates that past traditions are built into present ones, 
so it is impossible for us to escape our traditions. We should know that in the course of 
interpretation, the meaning we project to the situation is directly related to our traditions. In 
Gadamer’s view, tradition functions as a relevant authority, since it has preserved the 
wisdom of subsequent generations, and by listening to tradition, we can reach authentic 
understanding. In dialogue with the other person, the awareness of our tradition helps us to 
show openness to the tradition the other represents.  
6.2. Process of interpretation in reproductive genetic counselling 
In the following, the four-openness model of interpretation is applied to the process 
of genetic counselling, where both the counsellor and the counsellee influence each other, 
thus, they should understand the other person and the other’s role in the interaction [27]. 
Actually, double interpretation is performed; the counsellor interprets the counsellee, and 
the counsellee interprets the counsellor. An interpretation directed by the four-openness 
model yields the advantage of considering the four most important factors that affect the 
course of genetic counselling, i.e. the counsellor, the counsellee, the genetic risk or disease, 
and the contextual circumstances. Since, in the counselling relationship, the counsellor 
bears greater responsibility for the success of the consultation than the counsellee, the 
counsellor is expected to facilitate the counsellee’s interpretation process as well [28].  
6.2.1. Openness to the counsellor 
In genetic counselling, the openness to oneself demands the self-understanding of 
the genetic counsellor whose influence on the counsellee cannot be ignored. Thus, the 
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counsellor has to examine whether she accepts the promotion of the counsellees’ interest as 
the goal of her activity, and if she interprets her professional task as to discuss moral, 
social, and emotional questions besides the medical ones [152]. The counsellor should 
make clear for herself her view about the severity of the disease and the quality of life 
affected by the disorder. These value judgements are unavoidably reflected in the 
counsellor’s interpretation of genetic risk and in the description of the disease, so they may 
modify the counsellee’s perception of the problem. The counsellor has to admit her 
preliminary concept about the course of action to be followed by the counsellee as this 
preconception could cause difficulties if the counsellee’s idea differs from it. The 
counsellor’s communication style is also worthy of self-examination, since she is expected 
to have an ability to generate an atmosphere where open communication can occur. This 
solid self-knowledge makes possible that when the counsellee asks for advice, the 
counsellor can explore the social, religious, and emotional backgrounds on which her 
solution is based. By disclosing explicitly her value orientation, the counsellor assists the 
counsellee’s interpretation process, in which the counsellor is the other person whom the 
counsellee has to understand. On the basis of this transparency, women and couples can 
compare the counsellor’s value system to their own ones, and in accordance with this 
assessment, they can determine if they accept or refuse the counsellor’s advice [153].  
6.2.2. Openness to the counsellee 
The openness to the counsellee, the recognition of her difference is paramount in 
genetic counselling, because it determines the form of information and help. By showing 
openness to the counsellee, the counsellor does not remain untouched by her life problem, 
but she shares the troubles and difficulties the counsellee feels during the perception of the 
genetic information and in the decision-making process. The willingness of thinking with 
the counsellee gives authority to the counsellor to discuss questions belonging to the field 
of privacy. The counsellor needs to gain a notion about the vocabulary the other 
understands and the reasoning method she uses. Relying upon this knowledge, the 
counsellor has to adjust her communication style to that of the counselleee as the framing 
of information and the mode of reasoning affect the understanding of the situation of being 
at risk [154]. The counsellor explores the counsellee’s knowledge on the given disease and 
her perception about the severity of it. The counsellor gets impressions about how firm or 
vague the value system of the counsellee is, and how much help is necessary in its 
clarification. As, in the majority of cases, the parents visit the genetic counsellor together, 
the counsellor should involve both of them in the course of counselling. The counsellor 
pays attention to the dynamics of the couple’s relationship, since the couple’s disagreement 
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or their responsibilities to other children have a definitive effect on the decision. Emotions 
can also come to the surface, and the counsellor can assess the level of anxiety and its role 
in the process of understanding, which may indicate demand for psychological support 
[155]. The issues posed by the counsellor contribute not only to the counsellor’s effort to 
understand the patient, which is the basis for providing effective support, but also to the 
self-understanding of the counsellee, which is a pre-condition of careful decision making.  
6.2.3. Openness to the disease and its impacts 
In reproductive genetic counselling, the openness to the subject matter, i.e. to the 
genetic risk or disease, means that each life situation is unique, each parent reacts specially 
to the situation of having a high-risk pregnancy, so the counsellor should go through the 
interpretation process with each counsellee, even though the genetic disorder is the same. 
The counsellor presents the medical problem and the counsellee’s inquiry forces the 
counsellor to personalise the medical information to the counsellee’s needs. The 
counsellee’s questions are not restricted to the factual nature of the disorder but extend to 
value-laden problems too. For example, the counsellee would like to know the counsellor’s 
knowledge about life with a disabled baby or the counsellor’s choice if she were in the 
other’s place. The intention to enhance the counsellee’s deliberation allows the counsellor 
to introduce unsolicited information and to challenge poorly reasoned choices [156]. This 
professional behaviour does not violate counsellees’ autonomy but promotes cautious 
deliberation by drawing attention to unexplored problems. By the end of the open dialogue, 
the counsellee has completed her understanding with the counsellor’s wider knowledge 
about the medical aspects of the disorder, and the counsellor has enriched her 
understanding about the disease with the counsellee’s experience, which may be used as a 
starting point to understand other counsellees [32]. The common understanding of the 
situation enables the partners to find a solution together that is acceptable for the 
counsellee [157]. 
6.2.4. Openness to the cultural and social circumstances 
During open dialogues, the counsellee and the counsellor open up together the 
wider social and cultural contexts in which reproductive autonomy has got its meaning. 
The collective opinion on the acceptance of prenatal tests, on the termination of pregnancy, 
on living with disability, and on the parental responsibilities concerning the upbringing of a 
severely disabled child indicates to the parents the ways of conduct the community could 
accept. In Hungary, for example, the public opinion supports the termination of an affected 
pregnancy, honours families caring for children with Down’s syndrome, but rejects the 
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behaviour of the parents who abandon their disabled children and leave their care to state-
financed institutions. The social or familial expectations may be assessed as constraints on 
autonomy—although, only if autonomy is perceived as absolute freedom—but their 
acknowledgement helps parents prepare for unpleasant reactions and find coping strategies 
if they decide against the public opinion. In connection to medical genetics, the respect for 
traditions calls attention to the importance of two social value commitments, the rejection 
of eugenics and the respect for reproductive autonomy [158], which demand that the 
genetic counsellor should abstain from determining the content of the decision. 
6.3. Advantages and disadvantages of interpretive genetic counselling  
An advantage of interpretative genetic counselling appears in the feature that while 
the prevailing non-directive approach favours impartial information disclosure, the 
interpretive method, based on the true understanding of counsellees, offers the possibility 
of tailoring information to the real needs of counsellees. This new method also accepts that 
the counsellees’ expectations go beyond the limits of getting information and believes that 
the facilitation of counsellees’ decision-making and the provision of psychological support 
are essential parts of genetic counselling. By exploring the importance of the awareness of 
the counsellor’s prejudices and values, the interpretive approach presents advantages to 
those initiations as well that intend to support the patient’s deliberation by shared decision-
making, however, fail to examine the effect of the physician’s perspective on that activity 
[159]. 
The possibility that the counsellor’s involvement in the decision-making might 
encourage the revival of paternalism means a disadvantage for the interpretive approach. 
However, if clear distinctions are made between the interpretive method and medical 
paternalism, the respect for the reproductive liberty of counsellees and the active support of 
their decision-making could be simultaneously ensured. The Gadamerian thought implies 
the warnings that the physician cannot surely know what the patient’s perception about her 
best interest is, and therefore, it is inadmissible to force a solution on the patient. 
Regarding the positive features of the interpretive approach, I argue that the 
communication training of genetic counsellors should be completed with the discussion of 
the role of interpretation in the counselling interaction. Although interpretation is a genuine 
intellectual activity, which cannot be adequately performed by following a simplified 
algorithm, I’m convinced that the four-openness model of interpretation can work as a 
useful guideline for counsellors to engage in open dialogues with counsellees and to 
understand them.  
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7. Ethical importance of discussing publicly the pre- and 
postnatal issues of Down’s syndrome 
In our country, where, despite the fact that different screening methods are offered 
to pregnant women by university clinics and by other public or private health care 
institutions [160-168], a nationally organised prenatal Down’s syndrome screening 
programme has not yet been introduced, discussing publicly the issues of prenatal 
screening is much more demanding than in countries with well-organised screening 
programmes. In those countries where prenatal Down’s syndrome screening looks back to 
a three-decade long history, professionals of medical genetics have recognised that they 
should take responsibility for both the women who participate in screening and the patients 
who were born with the screened disorder [42]. In their views, this responsibility involves 
the acknowledgement of those social and ethical implications that are induced by the 
implementation of prenatal genetic screening and that influence the self-esteem and social 
status of individuals with disability. In Hungary, in the lack of a national prenatal screening 
policy on Down’s syndrome, the fulfilment of these tasks has remained to relevant 
scientific conferences, of which the most regularly held and the most comprehensive is the 
Down Syndrome Symposium of Szeged, organised by the local university’s Department of 
Medical Genetics. From its beginning in 1998, the Symposium has provided a nationwide 
forum for medical and non-medical professionals, for experts of prenatal and postnatal 
care, and for the parents having children with Down’s syndrome to present their activities 
and to acquire knowledge on the activities of the other parties (Table 9). In this chapter, the 
ethical impacts of the Symposium are examined from the viewpoints of prenatal screening 
and postnatal care. 
Table 9: Thematic division of presentations performed at Down Syndrome Symposiums of Szeged, 1998-2008 
Total   Topics 1st 
symp. 
2nd 
symp. 
3rd 
symp. 
4th 
symp. 
5th 
symp. 
6th 
symp. 
7th 
symp. n (%) 
1 Prenatal screening for DS 8 3 3 6 3 5 9 37 (31) 
2 Biomedical description of DS 6 1 1 4 1 2 - 15 (13) 
3 Ethical issues 3 3 2 1 2 2 1 14 (12) 
4 Children’s early intervention, education 2 2 3 1 2 2 - 12 (10) 
5 Postnatal medical problems 3 1 2 1 2 1 1 11 (9) 
6 Parent support groups’ activities 3 2 3 - - - 1 8 (7) 
7 Genetic diagnostic methods of DS 2 2 - - 2 - 1 7 (6) 
8 Epidemiology of DS 2 - 1 2 1 - 1 7 (6) 
9 Self-reports of parents, of adults with DS 2 1 - 3 - - 1 7 (6) 
DS = Down’s syndrome 
7.1. Impacts of public discourse on prenatal Down’s syndrome screening 
The topics of prenatal screening and diagnosis were extensively represented in the 
programmes of the subsequent symposiums (Table 9), which was owed to the professional 
orientations of the organisers and to the current state of prenatal Down’s syndrome 
screening in Hungary, which was aimed to be modified by the contributions of the 
screening professionals attending the meetings. 
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7.1.1. Gaining public support for the introduction of a formal prenatal Down’s 
syndrome screening programme  
One of the most significant issues where prenatal screening professionals have 
needed the support of health care policy makers and the wide public refers to the 
introduction of a universal prenatal Down’s syndrome screening programme. At the 
Symposium, the need to change the official screening concept, which was developed in the 
1980s and has included only the offer of amniocentesis for pregnant women aged 35 years 
or more, was justified by the reason that a scientifically outdated and ethically unjust 
screening policy should be stopped [43,44]. It was contended that only a formal screening 
programme could ensure the provision of screening to every pregnant woman, which was 
required by epidemiological data showing that in Hungary, between 2000-2004, among 
women giving birth to a Down’s syndrome baby, the proportion of those being younger 
than 35 years was around 60% [11]. Universal screening could also fulfil the requirement 
of justice by providing equal access of care for those women, who, because of their lower 
education and social status, could hardly access to prenatal screening. Practitioners also 
warned that for the introduction of a prenatal screening programme, a wide range of 
conditions should be guaranteed, e.g. technical equipments for screening and diagnosis; 
software programmes for risk calculation; training for practitioners; availability of genetic 
counselling, chorion villus sampling, amniocentesis, and pregnancy termination; and 
appropriate budget to finance the programme. Besides urging the implementation of a 
national screening programme, the Symposium has also intended to function as a post-
graduate training that informs practitioners about the latest screening technologies and 
about the ethical, psychological, and communication implications of prenatal Down’s 
syndrome screening, which should be addressed by a formal screening programme as well. 
Obviously, Down Syndrome Symposium has not been the only forum supporting 
the change of the official screening concept. For instance, in 2004, the College of Clinical 
Geneticists recommended performing 11-13 weeks ultrasound scan as a part of prenatal 
Down’s syndrome screening protocol, and offered maintaining the practice of second 
trimester ultrasound scan as well [12]. This measure has increased the spread of first 
trimester nuchal translucency screening, although, with significant regional differences 
[11]. Therefore, introducing a well-organised, national screening programme has remained 
a prominent task of health care policy, since by this programme, the use of outdated 
screening methods can be avoided, every pregnant woman can access to screening, and 
ethical, psychological and communication issues can be adequately addressed. 
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7.1.2. Building social consensus on the application of prenatal screening 
Discussing the topics of prenatal screening before an audience that involved 
parents, teachers, and physicians caring for children with Down’s syndrome might seem 
controversial, however, the vivid ethical debate emerging on the goal of prenatal screening 
among participants with different expertise and interest showed the benefit of the common 
forum. Eventually, in the lack of a national screening policy, the task of setting off a social 
debate on the application of Down’s syndrome screening was undertook by the 
Symposium. Including the public in the discussion of the ethical and social impacts of 
medical genetics is internationally encouraged [169], and this process is especially 
important in Hungary, where the tradition of debating health care issues publicly is young. 
Since many professionals confronted with the ethical and social issues of prenatal 
screening only at the Symposium, the forum has played a pivotal role in the 
acknowledgement of these contentious topics. 
Through the series of debates, some elements of a consensus on the implementation 
of prenatal Down’s syndrome screening were outlined. The parents’ sharp criticism on 
prevention as the aim of screening revealed that during the application of prenatal 
screening, not only the interests of pregnant women wanting to avoid the birth of a 
disabled child should be taken into consideration but also the interests and sensitivity of 
people living with disability [170]. The notes of the parents and paediatricians reminded 
screening professionals that because of their social responsibility towards disabled people, 
they should abstain from justifying screening by its potentials for decreasing the 
prevalence of Down’s syndrome or for sparing finances when its cost is compared with the 
cost of care of disabled patients. The right of parents for using prenatal screening 
technologies has been accepted even by families having children with Down’s syndrome 
[171]. However, the parents have expressed their wishes about using a language in public 
discourse that lacks discriminatory meaning against disabled people and does not include 
the assumption that the birth of a child with Down’s syndrome constitutes a tragedy. 
The personal experience that practitioners gained at the meetings played a decisive 
role in the modification of their opinions on some ethical questions. For example, a 
growing number of physicians have accepted that giving information about the genetic risk 
of the foetus should be considered as the aim of screening. Even though the aim of 
screening has remained a matter of debate, the initiation of the sixth symposium about 
omitting the phrase of prevention from public communication of prenatal screening issues 
gained wide support among providers of prenatal screening [172]. 
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7.2. Impacts of public discourse on postnatal care for people with 
Down’s syndrome 
By including the discussion of the medical, educational, and social questions of 
postnatal care of individuals with Down’s syndrome in the programme of the Symposium, 
the organisers have expressed the notion that the provision of prenatal screening and the 
improvement of the quality of life of people with disability are equally fundamental. 
Emphasising the importance of improved care and social inclusion of people with Down’s 
syndrome has of ethical importance as prenatal screening is frequently criticised for its 
features of strengthening negative attitudes towards disabled people and jeopardising the 
results of the disability rights movement [16]. Inviting paediatricians, public nurses, 
teachers, therapists, parents and adults with Down’s syndrome to present the issues of 
postnatal care can convey the message that screening professionals are aware of the 
possible negative impacts of prenatal screening and they want to avert them. 
7.2.1. Increasing public awareness about lives of people with Down’s syndrome 
Because of the scope of the audience, which was much wider than that of a 
traditional conference discussing separately the pre- and postnatal issues, the Symposium 
has fulfilled a special function in the increase of the community’s awareness about the day-
to-day lives of people with Down’s syndrome. Giving a realistic account on this issue is 
paramount, as the live of people with Down’s syndrome is hardly known by the wide 
public, and even by biomedical professionals who meet disabled people only in the 
medical setting [173]. Stemming from these reasons, prenatal screening professionals 
especially welcomed the lectures presenting the lived experience of people with disability 
as they could get first-hand information on the recent prospect of disabled people about 
which they rarely had any practical experience. Nonetheless, being well-informed about 
the educational and social opportunities provided for disabled people belongs to the 
professional requirements of screening practitioners, since they are expected to give 
pregnant women balanced information on Down’s syndrome. By making medical 
professionals aware of the non-medical characteristics of Down’s syndrome and of the 
support services available to disabled people, the Symposium has helped physicians to 
avoid giving parents biased information, which focuses mainly on the medical problems. 
At the meetings, the audience recognised with surprise how well-organised and 
strong the parent self-support groups were in Hungary, and how wide range of services 
were offered by them to promote families having a disabled child to control their lives. The 
capability of many people with Down’s syndrome to l
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the parents’ efforts for ensuring this kind of life for their children were almost unknown by 
the majority of the participant. The importance of changing the attitude of the public 
towards disabled people was illuminated by the experiences of the parents, which revealed 
that despite to legal guarantees, to find a supportive school remained difficult and disabled 
people had hardships in getting jobs after school years [174-176]. Although, for lay 
participants performing a lecture at a scientific meeting means a considerable challenge, 
their regular contributions have proved indispensable in reducing negative attitude towards 
disabled people and in modifying stereotypes associated with disability. 
7.2.2. Improving the quality of life of people with Down’s syndrome 
Besides giving forum to relevant lectures, the Symposium also supported the 
improvement of the lives of people with Down’s syndrome by giving opportunity for the 
parents and medical professionals to make contact and develop co-operation. The parents 
grasped this chance and addressed some fields where the two parties could mutually help 
each other. One of them referred to the issue of disclosing information about the 
affectedness of a newborn baby, and in order to prevent inappropriate practices, the parent 
support groups offered their help for obstetricians to develop a method of non-delayed, 
emphatic, and detailed information giving. The proposal was embraced and as a first step, 
a survey was conducted about the parents’ expectations on information by the National 
Institute of Epidemiology in order to help obstetricians to construct protocols on informing 
parents about the birth of a disabled child [177]. Another occasion for co-operation 
emerged in the field of psychological support of new parents, and obstetric units were 
requested to make the information available that families could get support from fellow 
parents if they asked for it. The parents initiated the implementation of Down’s syndrome 
clinics as well, since this outpatient care had been available only in the capital, and by the 
collaboration of paediatricians, a new clinic was established in the Department of 
Paediatrics, University of Szeged [178]. The familial climate of the Symposium, which 
was in great part generated by the parents who were accompanied by their children, 
promoted the frank dialogue and the co-operation of professional and lay participants. 
The ten-year long history of Down Syndrome Symposium of Szeged has shown 
that conferences discussing the pre- and postnatal aspects jointly can reconcile the claims 
of antenatal screening and the interests of people with disability. These meetings offer the 
chance to preserve important social and ethical values, e.g. justice, respect for reproductive 
autonomy, equal moral value of disabled people. Considering the implementation of this 
type of symposium would be especially useful in those countries where the introduction of 
a prenatal Down’s syndrome screening programme is in preparation. 
 40 
8. Conclusions 
In Hungary, the study of prenatal Down’s syndrome screening has represented the 
first example of a practice where a medical ethicist was deliberately involved in the work 
of a medical department in order to explore the ethical issues of this procedure. For me, as 
a medical ethicist, this co-operation offered a unique opportunity to combine medical 
ethics theories and the screening experiences of professionals and pregnant women. Using 
this approach, the following new results have been yielded by the PhD thesis: 
1) Ethical acceptability of prenatal Down’s syndrome screening: In the Thesis, I 
have challenged the popular idea that the goal of prenatal Down’s syndrome screening is 
disease prevention. I have asserted that this goal violates essential ethical norms, i.e. 
interferes with the reproductive autonomy of parents and includes eugenic and 
discriminatory hints against people with disability. I have contended that this medical 
procedure can be accepted on ethical grounds only if its goal is defined as enhancing the 
reproductive autonomy of parents and if the voluntary participation of women is ensured.  
2) Implications of an ethically justifiable aim on medical practice: I have stated 
that the goal of enhancing reproductive autonomy has an effect on the overall process of 
screening, especially on the applied screening technology, patient information, doctor-
patient relationship, and method of genetic counselling. 
Screening methods: On this issue, I have asserted that the great number of methods, 
concerns about reliability of data on efficacy of tests, changes of professional attitudes to 
ultrasound scan, wider spread of first trimester policies, and uncertainty about the role of 
maternal age in screening have led to confusion among practitioners and pregnant women. 
I have contended that the confusion on screening technology would be dissipated by 
professional guidelines, which have to include some basic requirements of tests, such as 
individual risk assessment, high sensitivity (85% or more), and low false positive rate (5% 
or less). Since not only one but some methods can meet these expectations, other needs 
deriving from specific medical, ethical or economic considerations can also be satisfied. 
Thus, I have proposed that professionals should clearly define what technology could fulfil 
best the given needs and these data should be disclosed to pregnant women. 
Information: I have emphasised that giving women pre- and post-test information 
should be considered an inherent part of screening. As, in my view, not only detailed but 
also personalised information is necessary to facilitate women’s decision, I have 
interpreted the professionals’ and the pregnant women’s attitudes to screening and have 
constructed a guideline to help professionals provide verbal or written pre-test information. 
I have suggested that an information leaflet should be given to all women prior to 
screening and communication training should be included in the post-graduate education of 
screening professionals, where the data of screening tests and the process of risk 
communication are taught. 
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Doctor-patient relationship: To get insight into the genetic counselling relationship, 
the views of counsellors on the goal of genetic counselling were explored, and a research 
was conducted on the genetic counselling expectations of pregnant women. Based on our 
research data, I have revealed that, besides detailed information and psychological support, 
women expected help with decision-making as well, and the fulfilments of expectations 
affected decisively the success of decision-making. Since, of the divergent genetic 
counselling methods promoted by counsellors, the interpretive method promised fulfilment 
of counsellees’ expectations, I have proposed a shift from recent counselling methods to 
interpretive genetic counselling. The results and proposals of our research inspired the 
editors-in chief of EJOG & RB to launch a debate on genetic counselling in the journal. 
Method of genetic counselling: In order to get knowledge about the counsellees’ 
expectations and to help their decision-making, I have asserted that counsellors should 
understand the counsellees’ situation. To promote the understanding process, I and a 
colleague have elaborated a methodological framework of interpretive genetic counselling 
that helps clarify the four most important factors of genetic counselling: the counsellor’s 
attitude; the counsellee’s values and needs; the medical, social, and moral impacts of the 
disease; and the social context. I think, if the interpretive method is properly applied, 
counsellors can give counsellees personalised information and emotional support, and can 
facilitate their careful deliberation without exerting paternalistic influence on them. 
3) Wider social impacts of prenatal Down’s syndrome screening: To emphasise 
the importance of taking into account both the needs of pregnant women and the interests 
of families having an affected child during the implementation of prenatal screening, I 
analysed the ten-year work of Down Symposium of Szeged that discussed jointly the 
issues of pre- and postnatal care. I have assessed the practice of the Symposium as worthy 
to follow, since it supported simultaneously the spread of prenatal screening and the 
improvement of the quality of life of people with disability. Concerning Down’s syndrome 
screening in Hungary, I have promoted the introduction of universal screening, since only 
a formal programme can prevent the use of outdated methods, can ensure every pregnant 
woman access to care, and can adequately address ethical and communication issues.  
In summary, the results of the Thesis can be applied as ethical guidelines by 
prenatal screening practitioners, relevant professional bodies, and health care policy 
makers. The data on the counselling expectations of women and the method of interpretive 
genetic counselling can be utilised by genetic counsellors and can be included in their post-
graduate training. In academic education, the Thesis can serve as an example to present 
how medical ethics theories and day-to-day medical experiences can be combined. For 
medical ethicist, the Thesis can function as an encouragement to conduct descriptive 
ethical researches by which the effects of the specific Hungarian health care context on the 
operation of widely accepted ethical norms could be explored.  
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